10-Hydroxy-2-decenoic acid from Royal jelly: A potential medicine for RA

Journal of Ethnopharmacology

Volumn 128, Issue 2, 2010, Pages 314-321

  Yang, Xin Yu ^a   Yang, De sheng ^a   Wei Zhang, ^a   Wang, Jian Min ^b   Li, Chun Yang ^a   Hui Ye, ^a   Lei, Kang Fu ^a   Chen, Xiu Fang ^a   Shen, Nian Han ^a   Jin, Li Qin ^a   Wang, Jian Guang ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Jiamusi Central Hospital   (China)

Author keywords

10H2DA; MMP; Rheumatoid arthritis; Royal jelly

Indexed keywords

10 HYDROXY 2 DECENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; JANUS KINASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; ROYAL JELLY; STROMELYSIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ALKALINITY; ARTICLE; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; DRUG ACTIVITY; DRUG DETERMINATION; DRUG ISOLATION; DRUG POTENCY; DRUG PURIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SOLUTION AND SOLUBILITY; TISSUE CULTURE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FIBROBLASTS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASES; NF-KAPPA B; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

APIS MELLIFERA;

EID: 77649187668     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.01.055     Document Type: Article

References (52)

1. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., and Luthra H.S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31 (1988) 315-324
2. Baldwin A.S.J. The NF-κB and I κB proteins: new discoveries and insights. Annual Review of Immunology 14 (1996) 649-683
3. Bincoletto C., Eberlin S., Figueiredo C.A., Luengo M.B., and Queiroz M.L. Effects produced by royal jelly on haematopoiesis: relation with host resistance against Ehrlich ascites tumour challenge. International Immunopharmacology 5 (2005) 679-688
4. Blum M.S., Novak A.F., and Taber S. 10-Hydroxy-delta 2-decenoic acid, an anti-biotic found in royal jelly. Science 130 (1959) 452-453
5. Cheng S.M., Yang S.P., Ho L.J., Tsao T.P., Juan T.Y., Chang D.M., Chang S.Y., and Lai J.H. Down-regulation of c-jun N-terminal kinase-activator protein-1 signaling pathway by Ginkgo biloba extract in human peripheral blood T cells. Biochemical Pharmacology 66 (2003) 679-689
6. El-Nekeety A.A., El-Kholy W., Abbas N.F., Ebaid A., Amra H.A., and Abdel-Wahhab M.A. Efficacy of royal jelly against the oxidative stress of fumonisin in rats. Toxicon 50 (2007) 256-269
7. Feldmann M., Brennan F.M., and Mainin R.N. Rheumatoid arthritis. Cell 85 (1996) 307-310
8. Firestein G.S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis and Rheumatism 39 (1996) 1781-1790
9. Fujiwara S., Imai J., Fujiwara M., Yaeshima T., Kawashima T., and Kobayashi K. A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin. The Journal of Biological Chemistry 265 (1990) 11333-11337
10. Ganesan K., Tiwari M., Balachandran C., Manohar B.M., and Puvanakrishnan R. Estrogen and testosterone attenuate extracellular matrix loss in collagen-induced arthritis in rats. Calcified Tissue International 83 (2008) 354-364
11. Garrington T.P., and Johnston G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Current Opinion in Cell Biology 11 (1999) 211-218
12. Green M.J., Gough A.K., Devlin J., Smith J., Astin P., Taylor D., and Emery P. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 42 (2003) 83-88
13. Han Z., Boyle D.L., Chang L., Bennett B., Karin M., Yang L., Manning A.M., and Firestein G.S. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. The Journal of Clinical Investigation 108 (2001) 73-81
14. Hee-Jin Y., Wan-Hee Y., Myung-Kwan H., Young-Rae L., Jong-Suk K., and Sang-Il L. Epigallocatechin-3-gallate suppresses TNF-α-induced production of MMP-1 and -3 in rheumatoid arthritis synovial fibroblasts. Rheumatology International 29 (2008) 23-29
15. Ho L.J., Lin L.C., Hung L.F., Wang S.J., Lee C.H., Chang D.M., Lai J.H., and Tai T.Y. Retinoic acid blocks pro-inflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes. Biochemical Pharmacology 70 (2005) 200-208
16. Inoue S., Koya-Miyata S., Ushio S., Iwaki K., Ikeda M., and Kurimoto M. Royal jelly prolongs the life span of C3H/HeJ mice: correlation with reduced DNA damage. Experimental Gerontology 38 (2003) 965-969
17. Jennings K., Miyamae T., Traister R., Marinov A., Katakura S., Sowders D., Trapnell B., Wilson J.M., Gao G., and Hirsch R. Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo. Molecular Therapy 11 (2005) 600-607
18. Jovanovic D.V., Martel-Pelletier J., Di Battista J.A., Mineau F., Jolicoeur F.C., Benderdour M., and Pelletier J.P. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis and Rheumatism 43 (2000) 1134-1144
19. Jurzak M., Latocha M., Gojniczek K., Kapral M., Garncarczyk A., and Pierzchała E. Influence of retinoids on skin fibroblasts metabolism in vitro. Acta Poloniae Pharmaceutica 65 (2008) 85-91
20. Kamakura M., Mitani N., Fukuda T., and Fukushima M. Antifatigue effect of fresh royal jelly in mice. Journal of Nutritional Science and Vitaminology 47 (2001) 394-401
21. Keyszer G., Lambiri I., Nagel R., Keysser C., Keysser M., Gromnica-Ihle E., Franz J., Burmester G.R., and Jung K. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1) and MMP-1/TIMP-1 complexes in rheumatic diseases: correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. The Journal of Rheumatology 26 (1999) 251-258
22. Khalkhali-Ellis Z., Seftor E.A., Nieva D.R., Handa R.J., Price, Kirschmann D.A., Baragi V.M., Sharma R.V., Bhalla R.C., Moore T.L., and Hendrix M.J. Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthritis. The Journal of Rheumatology 27 (2000) 1622-1631
23. Kirchmeyer M., Deffaud J., Sebillaud S., Moulin D., Koufany M., Netter P., Bianchi A., and Jouzeau J.Y. Evidence for species differences in the regulation of MMPs by all-trans retinoic acid in cytokine-stimulated chondrocytes. Biorheology 45 (2008) 415-432
24. Kohno K., Okamoto I., Sano O., Arai N., Iwaki K., Ikeda M., and Kurimoto M. Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Bioscience, Biotechnology and Biochemistry 68 (2004) 138-145
25. Lally F., Smith E., Filer A., Stone M.A., Shaw J.S., Nash G.B., Buckley C.D., and Rainger G.E. A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium. Arthritis and Rheumatism 52 (2005) 3460-3469
26. Lichtenthaler R., and Marx F. Total oxidant scavenging capacities of common European fruit and vegetable juices. Journal of Agricultural and Food Chemistry 53 (2005) 103-110
27. Lories R.J., Derese I., Ceuppens J.L., and Luyten F.P. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis and Rheumatism 48 (2003) 2807-2818
28. MacNaul K.L., Chartrain N., Lark M., Tocci M.J., and Hutchinson N.I. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-α on stromelysin expression. The Journal of Biological Chemistry 265 (1990) 17238-17245
29. Matsui T., Yukiyoshi A., Doi S., Sugimoto H., Yamada H., and Matsumoto K. Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. The Journal of Nutritional Biochemistry 13 (2002) 80-86
30. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., and Brinckerhoff C.E. Interleukin-1 induction of collagenase-3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB: differential regulation of collagenase 1 and collagenase 3. Arthritis and Rheumatism 43 (2000) 801-811
31. Okamoto I., Taniguchi Y., Kunikita T., Kohno K., Iwaki K., Ikeda M., and Kurimoto M. Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sciences 1 (2003) 2029-2045
32. Okuda H., Kameda K., Morimoto C., Matsuura Y., Chikaki M., and Ming J. Studies on insulin-like substances and inhibitory substances toward angiotensin-converting enzyme in royal jelly. Honeybee Science 19 (1998) 9-14 (in Japanese)
33. Pap T., van der Laan W.H., Aupperle K.R., Gay R.E., Verheijen J.H., Firestein G.S., Gay S., and Neidhart M. Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis. Arthritis and Rheumatism 43 (2000) 2531-2536
34. Reunanen N., Li S.P., Ahonen M., Foschi M., Han J., and Kahari V.M. Activation of p38 α MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. The Journal of Biological Chemistry 277 (2002) 32360-32368
35. Sarma P.K., Misra R., and Aggarwal A. Elevated serum receptor activator of NFκB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)-3, and ProMMP-1 in patients with juvenile idiopathic arthritis. Clinical Rheumatology 27 (2008) 389-394
36. Satomi K.M., Iwao O., Shimpei U., Kanso I., Masao I., and Masashi K. Identification of a collagen production-promoting factor from an extract of royal jelly and its possible mechanism. Bioscience, Biotechnology and Biochemistry 68 (2004) 767-773
37. Sauerwald N., Polster J., Bengsch E., Niessen L., and Vogel R.F. Combined antibacterial and antifungal properties of water-soluble fraction of royal jelly. Advances in Food Sciences 20 (1998) 46-52
38. Schett G., Tohidast-Akrad M., Smolen J.S., Schmid B.J., Steiner C.W., Bitzan P., Zenz P., Redlich K., Xu Q., and Steiner G. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis and Rheumatism 43 (2000) 2501-2512
39. Segar R., and Krebs E.G. The MAPK signaling cascade. The FASEB Journal 9 (1995) 726-735
40. Takenaka T. Chemical composition of royal jelly. Honeybee Science 3 (1982) 69-74
41. Tetlow L.C., and Wolley D.E. Comparative immuno-localization studies of collagenase-1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. British Journal of Rheumatology 37 (1998) 64-70
42. Townsend G.F., Morgan J.F., and Hazlett B. Activity of 10-hydroxydecenoic acid from royal jelly against experimental leukemia and ascetic tumors. Nature 183 (1959) 1270-1271
43. Townsend G.F., Morgan J.F., Tolnai S., Hazlett B., Morton H.J., and Shuel R.W. Studies on the in vitro antitumor activity of fatty acid I, 10-hydroxy-2-decenoic acid from royal jelly. Cancer Research 20 (1960) 503-510
44. Townsend G.F., Brown W.H., Fleeter E.E., and Hazlett B. Studies on the in vitro antitumor activity of fatty acid IV. The esters of acids closely relate to 10-hydroxy-2-decenoic acid from royal jelly against transplantable mouse leukemia. Canadian Journal of Biochemistry and Physiology 39 (1961) 1765-1770
45. Uzbekova D., Chugunova L., Makarova V., Ryabkov A., and Mirgorodskaya L. Efficacy of royal jelly and lactulose on thyroxin-induced liver damage in rats. Hepatology 28 (2006) 157
46. Vincenti M.P., Coon C.I., and Brinckerhoff C.E. Nuclear factor κB/p50 activates an element in the distal matrix metalloproteinase-1 promoter in IL-1β-stimulated synovial fibroblasts. Arthritis and Rheumatism 41 (1998) 1987-1994
47. Vittek J. Effect of royal jelly on serum lipids in experimental animals and humans with atherosclerosis. Experientia 51 (1995) 927-935
48. Walakovits L.A., Moore V.L., Bhardwaj N., Gallick G.S., and Lark M.W. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis and Rheumatism 35 (1992) 35-42
49. Watanabe K., Shinmoto H., Kobori M., Tsushida T., Shimohara K., Kanaeda J., and Yonekura M. Growth stimulation with honey royal jelly DIII protein of human lymphocytic cell lines in a serum-free medium. Biotechnology Techniques 10 (1996) 959-962
50. Watanabe K., Shinmoto H., Kobori M., Tsushida T., Shimohara K., Kanaeda J., and Yonekura M. Stimulation of cell growth in the U-937 human myeloid cell line by honey royal jelly protein. Cytotechnology 26 (1998) 23-27
51. Yoshihara Y., Nakamura H., Obata K., Yamada H., Hayakawa T., Fujikawa K., and Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluid from patients with rheumatoid arthritis or osteoarthritis. Annals of Rheumatic Diseases 59 (2000) 455-461
52. Zimmermann A. Liver regeneration: the emergence of new pathways. Medical Science Monitor 8 (2002) 53-63